Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Urinary Bladder Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 6Breast Neoplasms 6Carcinoma, Transitional Cell 5Stomach Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Neoplasms 3Neoplasm Metastasis 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Tumor Virus Infections 1Thrombocytosis 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrent Bladder Urothelial Carcinoma 1Recurrence 1

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Sunitinib 1Lapatinib 1Imatinib Mesylate 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Albumin-Bound Paclitaxel × Genitourinary × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡